vs
Applied Therapeutics, Inc.（APLT）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Applied Therapeutics, Inc.的季度营收约是Arcadia Biosciences, Inc.的1.1倍（$1.0M vs $901.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -1899.0%，领先1750.7%），Applied Therapeutics, Inc.同比增速更快（719.7% vs -25.8%）
Relief Therapeutics是一家总部位于日内瓦的瑞士生物制药企业，专注于为现有治疗方案稀缺或空白的重症领域研发创新药物。其核心在研药物RLF-100是一种可保护肺部的天然肽合成制剂，公司于2016年在瑞士证券交易所挂牌上市。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
APLT vs RKDA — 直观对比
营收规模更大
APLT
是对方的1.1倍
$901.0K
营收增速更快
APLT
高出745.5%
-25.8%
净利率更高
RKDA
高出1750.7%
-1899.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0M | $901.0K |
| 净利润 | $-19.0M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -1675.8% | -152.8% |
| 净利率 | -1899.0% | -148.3% |
| 营收同比 | 719.7% | -25.8% |
| 净利润同比 | 72.3% | 67.1% |
| 每股收益（稀释后） | $-0.13 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLTRKDA
| Q4 25 | — | $901.0K | ||
| Q3 25 | $1.0M | $1.3M | ||
| Q2 25 | $0 | $1.5M | ||
| Q1 25 | $0 | $1.2M | ||
| Q4 24 | $-1.0K | $1.2M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | $144.0K | $1.3M | ||
| Q1 24 | $190.0K | $987.0K |
净利润APLTRKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-19.0M | $856.0K | ||
| Q2 25 | $-21.3M | $-4.5M | ||
| Q1 25 | $-21.8M | $2.6M | ||
| Q4 24 | $44.0M | $-4.1M | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | $2.9M | $1.1M | ||
| Q1 24 | $-83.9M | $-2.4M |
毛利率APLTRKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率APLTRKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -1675.8% | -88.5% | ||
| Q2 25 | — | -34.4% | ||
| Q1 25 | — | 44.2% | ||
| Q4 24 | 3302300.0% | -187.7% | ||
| Q3 24 | — | -114.5% | ||
| Q2 24 | -14194.4% | — | ||
| Q1 24 | -11101.6% | -160.9% |
净利率APLTRKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -1899.0% | 65.7% | ||
| Q2 25 | — | -306.4% | ||
| Q1 25 | — | 216.6% | ||
| Q4 24 | -4400700.0% | -334.5% | ||
| Q3 24 | — | -104.9% | ||
| Q2 24 | 2012.5% | 81.2% | ||
| Q1 24 | -44177.9% | -245.5% |
每股收益（稀释后）APLTRKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-0.13 | $0.62 | ||
| Q2 25 | $-0.15 | $-3.26 | ||
| Q1 25 | $-0.15 | $1.90 | ||
| Q4 24 | $0.52 | $-2.99 | ||
| Q3 24 | — | $-1.18 | ||
| Q2 24 | $-0.13 | $0.78 | ||
| Q1 24 | $-0.67 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.9M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-561.0K | $4.1M |
| 总资产 | $34.4M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLTRKDA
| Q4 25 | — | $4.6M | ||
| Q3 25 | $11.9M | $5.9M | ||
| Q2 25 | $30.4M | $4.4M | ||
| Q1 25 | $50.8M | $3.2M | ||
| Q4 24 | $79.4M | $4.2M | ||
| Q3 24 | — | $6.6M | ||
| Q2 24 | $122.2M | $8.1M | ||
| Q1 24 | $146.5M | $8.5M |
股东权益APLTRKDA
| Q4 25 | — | $4.1M | ||
| Q3 25 | $-561.0K | $5.4M | ||
| Q2 25 | $17.4M | $4.5M | ||
| Q1 25 | $36.7M | $8.9M | ||
| Q4 24 | $57.0M | $6.2M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | $72.4M | $11.7M | ||
| Q1 24 | $67.3M | $10.6M |
总资产APLTRKDA
| Q4 25 | — | $6.5M | ||
| Q3 25 | $34.4M | $8.6M | ||
| Q2 25 | $37.3M | $7.8M | ||
| Q1 25 | $56.9M | $13.0M | ||
| Q4 24 | $86.7M | $13.5M | ||
| Q3 24 | — | $15.2M | ||
| Q2 24 | $127.8M | $17.4M | ||
| Q1 24 | $151.2M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.4M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流APLTRKDA
| Q4 25 | — | $-861.0K | ||
| Q3 25 | $-18.4M | $-257.0K | ||
| Q2 25 | $-20.3M | $-2.0M | ||
| Q1 25 | $-28.6M | $-1.6M | ||
| Q4 24 | $-19.5M | $-2.2M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | $-22.6M | $-2.5M | ||
| Q1 24 | $-18.9M | $-3.2M |
自由现金流APLTRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-2.5M | ||
| Q1 24 | — | $-3.2M |
自由现金流率APLTRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -188.3% | ||
| Q1 24 | — | -326.5% |
资本支出强度APLTRKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 1.3% |
现金转化率APLTRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | -0.44× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -7.80× | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
